Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Buy the Dip in PPG for a 2026 Rebound — Tactical Long with Defined Stops
2025 weakness is largely cyclical; cash flow and dividend intact — position for margin recovery in 2026
PPG shares weakened through 2025 as revenues fell and margins compressed, but the company still generates strong operating cash flow, supports a ~2.7%...
Wyndham Hotels - Weakness After Newsflow Creates a Tactical Long Opportunity
Franchise cash flows intact, yield rising and valuation compressed — buy a measured starter position around $76 with defined stops and clear upside targets.
Wyndham (WH) has sold off from its summer highs after headline risk and near-term uncertainty. Fundamentals remain solid: recurring franchise revenue,...
Hudbay Looks Like a Copper-Cycle Winner — Tactical Long with Defined Stops and Targets
Rising copper demand and supply tightness give Hudbay (HBM) upside; trade idea with entry, stop, targets and risk framework.
Hudbay Minerals (HBM) has rallied sharply this year as copper tightness and renewed investor appetite for base-metals plays push smaller producers int...
PG&E (PCG) Looks Cheap Relative to Cash Flow and Balance Sheet - A Tactical Long
Strong operating cash, rising dividend and activist interest make a case for buying; manage wildfire/regulatory and capex risk with a tight stop.
PG&E's operating cash generation remains robust even as the company invests aggressively in California grid hardening. At ~15.78 per share and an impl...
Meta: Capturing the AI Ad Wave Now — Trade Idea with Entries, Stops and Targets
Strong cash flow, aggressive R&D, and near-term ad upside make Meta a tactical long on AI monetization.
Meta is already monetizing large language models and recommendation improvements across its Family of Apps. With trailing revenue roughly $189.5B and ...
AZZ Looks Cheap for a Reason - But the Discount Is Too Wide
A tactical long: capital-light infrastructure + durable cash flow, priced like a cyclical distressed name
AZZ Inc. (AZZ) is trading at an arguably low multiple vs. an earnings run-rate that has improved materially across the last year. Recent quarters show...
BlackRock: Buy the Global Franchise, Trim the Valuation Risk
A position trade on the world’s largest asset manager — buy weakness, target a 20-25% upside with disciplined stops
BlackRock (BLK) remains the dominant owner of global passive and institutional flows with $13.464 trillion AUM as of 09/30/2025. The business prints s...
Investing the FCC Shakeup: A Tactical Long on Red Cat (RCAT) Amid NDAA Section 1709 Momentum
Small-cap drone maker with cash runway and product wins; trade it as a high-risk, event-driven long with strict stops
Red Cat (RCAT) stands to be an early beneficiary of accelerated enforcement of NDAA Section 1709 and recent FCC action limiting certain foreign drones...
Rocket Pharmaceuticals: Buy the FDA Overhang — LAD-I Approval and Danon Rewrite Could Reprice RCKT
Deep dislocation: meaningful cash on the balance sheet + program value vs. legal/FDA overhang creates asymmetric upside.
Rocket Pharmaceuticals (RCKT) trades with an FDA/legal overhang after a protocol change and clinical hold headlines. The company still holds roughly $...
ARCC At The Crossroads: Income, NAV, and the Private-Credit Showdown
Ares Capital looks cheap relative to book and pays a near-10% yield — trade the gap vs. private-credit peers with defined risk.
Ares Capital (ARCC) is trading around book value with an annualized dividend of $1.92 (about 9.6% yield) and last twelve-month net income roughly matc...
Tesla: Betting on Megablock Scale vs. Near-Term Auto Margin Pressure
A tactical long on pullbacks — play the engineering roadmap while respecting automotive margin risk
Tesla is executing a high-stakes scaling program (gigacells, expanded battery capacity, FSD/AI investments) that can justify premium multiples if exec...
Buy SentinelOne on a Data-and-Cloud Recovery: Target $20/$26 into 2026
Q2 revenue momentum, improving cash metrics and a clean balance sheet make S a tactical long with defined risk controls
SentinelOne's Q2 (period ended 07/31/2025) results show healthy revenue growth, a strong gross margin profile and a balance sheet that supports contin...